China, COVID-19 Update: release vaccine by November
Covid19: China has promised to release vaccine by November
China’s government says it may have a corona virus vaccine available publicly by November.
Hundreds of thousands of Chinese have already been injected with experimental vaccines. With at least three companies there in the final stages of clinical trials.
But some people are accusing the government of using a potential vaccine to expand its influence globally.
More news about COVID-19 vaccine
China has publicly presented its homegrown COVID-19 vaccines for the first time, as the country where the virus was first discovered, looks to shape the narrative surrounding the pandemic.
A lot of high hopes hang on the vaccine candidates produced by Chinese companies. Sinovac Biotech and Sinopharm which are on display at a Beijing trade fair this week.
Although none of these vaccine candidates has hit the market. After all-important phase 3 trials, the drugmakers approval is certain.
The Chinese state media and officials are making attempts to show the progress on domestic vaccines as a sign of Chinese leadership and resilience in the face of an unprecedented health threat that has pummeled the global economy.
Sinopharm said that it expects the antibodies from its jab to last between 1 and 3 years. Although the final result will only be made available after the trials.
Just so you know
A Chinese media outfit had last month reported that the price of the vaccines will not be high. The report quoted the Sinopharm’s Chairman as saying that every 2 doses of its vaccine should cost below $146. Meanwhile also telling the media that he has already been injected with one of the candidate vaccines.
China’s official Xinhua news agency reported Monday that another vaccine candidate which is being developed by Chinese military scientists can deal with mutations in the coronavirus.
As of last month, about 5.7 billion doses of the vaccines under development around the world had been pre-ordered.
However, the World Health Organization has warned that widespread immunization against Covid-19 may not be on the cards until the middle of next year.